Nanalysis Scientific Corp.
NSCIF
$0.09
$0.00-3.71%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 28.99M | 28.70M | 29.82M | 30.83M | 32.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.99M | 28.70M | 29.82M | 30.83M | 32.30M |
| Cost of Revenue | 22.04M | 21.58M | 21.79M | 22.07M | 22.87M |
| Gross Profit | 6.95M | 7.12M | 8.04M | 8.76M | 9.43M |
| SG&A Expenses | 6.87M | 7.23M | 7.69M | 8.08M | 8.20M |
| Depreciation & Amortization | 2.29M | 2.28M | 2.69M | 2.89M | 2.97M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.58M | 31.40M | 32.51M | 33.41M | 34.32M |
| Operating Income | -2.59M | -2.70M | -2.68M | -2.58M | -2.02M |
| Income Before Tax | -4.06M | -4.04M | -8.85M | -8.98M | -8.88M |
| Income Tax Expenses | 3.50K | 12.40K | 4.60K | -4.80K | 15.40K |
| Earnings from Continuing Operations | -4.07 | -4.06 | -8.86 | -8.97 | -8.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.07M | -4.06M | -8.86M | -8.97M | -8.90M |
| EBIT | -2.59M | -2.70M | -2.68M | -2.58M | -2.02M |
| EBITDA | -2.13M | -1.71M | -1.62M | -756.40K | 502.70K |
| EPS Basic | -0.03 | -0.04 | -0.08 | -0.08 | -0.08 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.04 | -0.04 | -0.08 | -0.08 | -0.08 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 482.47M | 458.81M | 454.72M | 453.00M | 452.49M |
| Average Diluted Shares Outstanding | 482.47M | 458.81M | 454.72M | 453.00M | 452.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |